Alnylam Pharmace. buy WatchMen
Start price
16.10.19
/
50%
€73.50
Target price
09.02.20
-
Performance (%)
54.50%
End price
09.02.20
€113.56
Summary
This prediction ended on 09.02.20 with a price of €113.56. The BUY prediction by WatchMen for Alnylam Pharmace. saw massive gains of 54.50%. WatchMen has 50% into this predictionAlnylam Pharmaceuticals, Inc. (ALNY) is a biopharmaceutical company focused on the development of RNA interference (RNAi) therapeutics. Its lead drug, ONPATTRO®, is approved by the U.S. FDA for the treatment of adults with polyneuropathy of hereditary transthyretin-mediated (hATTR) amyloidosis. The company is also developing additional RNAi therapeutic candidates for the treatment of a range of diseases, including cancer, cardiovascular disease, and viral infections. With a market capitalization of over $15 billion, Alnylam is one of the largest biotech companies in the world.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Alnylam Pharmace. | -0.211% | -0.211% | 35.227% | 51.013% |
| iShares Core DAX® | 3.023% | 2.202% | 14.664% | 48.878% |
| iShares Nasdaq 100 | 3.561% | 1.325% | 31.410% | 83.744% |
| iShares Nikkei 225® | 6.618% | 5.707% | 49.420% | 60.392% |
| iShares S&P 500 | 2.635% | 1.008% | 25.116% | 61.272% |
Comments by WatchMen for this prediction
In the thread Alnylam Pharmace. diskutieren
Buy Alnylam Pharmace.